• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA CENTAUR XPT TOTAL HCG (THCG) ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA CENTAUR XPT TOTAL HCG (THCG) ASSAY Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/15/2023
Event Type  malfunction  
Manufacturer Narrative
An outside the united states customer obtained a discordant elevated advia centaur xpt - total hcg (thcg) result for a pregnant female patient.The initial result was reported to the physician, who questioned the results.The sample was remeasured twice on same advia centaur xpt, and the results were lower.This sample was also diluted onboard with the dilutions of 1:10, 1:100 and 1:200 and all the diluted results resulted as errors.Quality control was in range at the time of testing and no instrument errors were found with the system during this event.The interpretation of results section of the advia centaur xpt total hcg instructions for use states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." siemens continues to investigate.
 
Event Description
The customer obtained a discordant elevated advia centaur xpt - total hcg (thcg) result for a pregnant female patient.The initial result was reported to the physician, who questioned the results.The sample was remeasured twice on same advia centaur xpt, and the results were lower.There are no reports that treatment was altered or prescribed or adverse health consequences due to the discordant advia centaur xpt total hcg result.
 
Manufacturer Narrative
Initial mdr 1219913-2023-00044 was filed on (b)(6) 2023 reporting a customer from outside the united states obtained a discordant elevated advia centaur xpt - total hcg (thcg) result for a pregnant female patient.The initial result was reported to the physician, who questioned the results.The sample was remeasured twice on same advia centaur xpt, and the results were lower.This sample was also diluted onboard with the dilutions of 1:10, 1:100 and 1:200 and all the diluted results resulted as errors.Additional information - (b)(6) 2023.The customer observed a falsely elevated, non-reproducible total human chorionic gonadotropin (thcg) patient sample using reagent lot 341 on an advia centaur xpt.On (b)(6) 2023, an initial thcg result of 670.2 miu/ml was reported to the physician and questioned.The sample was re-centrifuged and repeated, which produced results of 45.4 miu/ml and 56.5 miu/ml, the former of which was reported to and accepted by the physician.Biorad controls were within expected ranges, and no instrument errors were reported during the day of this event.There were no issues with other samples tested on the day of this event.The instrument was serviced on (b)(6) 2023 in which reagent probes were recalibrated, and the reagent mixer and acid/base pumps were checked.These service actions are considered normal troubleshooting for an issue of this nature.Thcg precision was verified following service and was acceptable.Based on available information, the cause of the discordant result is consistent with sample integrity and/or a sample handling issue.No potential product issue is observed.The customer is operational.In section h6, the investigation finding, and investigation conclusion codes were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XPT TOTAL HCG (THCG) ASSAY
Type of Device
TOTAL HCG (THCG) ASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
7818564812
MDR Report Key16486178
MDR Text Key310811872
Report Number1219913-2023-00044
Device Sequence Number1
Product Code JHI
UDI-Device Identifier00630414505176
UDI-Public00630414505176
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K925277
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/06/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/08/2023
Device Model NumberN/A
Device Catalogue Number10308985
Device Lot Number341
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/08/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age29 YR
Patient SexFemale
-
-